Cargando…
CTD与PCD方案治疗新诊断多发性骨髓瘤患者的疗效、预后及安全性分析
OBJECTIVE: To observe the efficacy and safety of CTD (cyclophosphamide, thalidomide, dexamethasone) and PCD (bortezomib, cyclophosphamide, dexamethasone) regimens in treatment of patients with newly diagnosed multiple myeloma (NDMM). METHODS: A retrospective analysis was carried out on 88 cases of N...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342733/ https://www.ncbi.nlm.nih.gov/pubmed/28468087 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.04.004 |